#biotherapeutics

Techseriesinsight > Blog > #biotherapeutics

June 12, 2025
PRNewswire
Biotechnology

Nona Biosciences and Visterra Partner to Advance Next-Generation Biotherapeutics for Immune-Mediated and Autoimmune Diseases

Nona Biosciences, a global biotechnology company providing integrated solutions from “Idea to IND” (I to ITM), today announced a license agreement with Visterra, Inc. to advance Visterra’s next-generation biotherapeutic pipeline for immune-mediated...

May 9, 2025
PRNewswire
Biotechnology

IASO Bio Receives Orphan Drug Designation from the Saudi Food and Drug Authority for Equecabtagene Autoleucel

IASO Biotherapeutics (“IASO Bio”), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced that its self-developed BCMA-targeted CAR-T cell...